These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2878724)

  • 21. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart.
    Chatelain P; Meysmans L; Mattéazzi JR; Beaufort P; Clinet M
    Br J Pharmacol; 1995 Oct; 116(3):1949-56. PubMed ID: 8640331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the surviving catecholamine-insensitive myocardium.
    Baumann G; Felix SB; Heidecke CD; Riess G; Loher U; Ludwig L; Blömer H
    Agents Actions; 1984 Oct; 15(3-4):216-28. PubMed ID: 6151806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone.
    Navarro HA; Kudlacz EM; Slotkin TA
    Biol Neonate; 1991; 60(2):127-36. PubMed ID: 1657219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The selective action of beta-adrenoceptor blocking drugs and the nature of beta1 and beta2 adrenoceptors.
    Coleman AJ; Somerville AR
    Br J Pharmacol; 1977 Jan; 59(1):83-93. PubMed ID: 13902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtype selective regulation of coupling of rat cardiac beta adrenoceptors to adenylate cyclase.
    Arnold IR; Mistry R; Barnett DB
    Eur J Pharmacol; 1993 May; 245(3):285-9. PubMed ID: 8392940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment.
    Michel MC; Pingsmann A; Beckeringh JJ; Zerkowski HR; Doetsch N; Brodde OE
    Br J Pharmacol; 1988 Jul; 94(3):685-92. PubMed ID: 2902891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds G; Taylor SH
    Eur J Clin Pharmacol; 1986; 29(6):659-65. PubMed ID: 2872054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in cardiac membrane beta-adrenoceptors and adenylyl cyclase due to hypochlorous acid.
    Persad S; Elimban V; Siddiqui F; Dhalla NS
    J Mol Cell Cardiol; 1999 Jan; 31(1):101-11. PubMed ID: 10072719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid hormone differentially regulates development of beta-adrenergic receptors, adenylate cyclase and ornithine decarboxylase in rat heart and kidney.
    Pracyk JB; Slotkin TA
    J Dev Physiol; 1991 Oct; 16(4):251-61. PubMed ID: 1667405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A different desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline.
    Nanoff C; Freissmuth M; Tuisl E; Schütz W
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):198-203. PubMed ID: 2468946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of myocardial beta-adrenergic receptor density and adenylate cyclase activity after human heart transplantation.
    Cruz Caturla M; Masotti M; Brodde OE; Hjemdahl P; Velasquez D; Turá A; Crexells C
    J Heart Lung Transplant; 1992; 11(6):1059-65. PubMed ID: 1333799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-adrenergic-mediated Cl secretion: evidence for additional non-cAMP-dependent pathway of effect.
    Feldman RD; Brotherton A; Welsh MJ
    Am J Physiol; 1990 Dec; 259(6 Pt 1):L426-31. PubMed ID: 2175556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals.
    Persad S; Takeda S; Panagia V; Dhalla NS
    J Mol Cell Cardiol; 1997 Feb; 29(2):545-58. PubMed ID: 9140814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of myocardial beta-adrenoceptor subtypes and coupling to the adenylate cyclase in children with congenital heart disease and implications for treatment.
    Kozlik-Feldmann R; Kramer HH; Wicht H; Feldmann R; Netz H; Reinhardt D
    J Clin Pharmacol; 1993 Jul; 33(7):588-95. PubMed ID: 8396157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertrophic cardiomyopathy characterised by beta-adrenoceptor density, relative amount of beta-adrenoceptor subtypes and adenylate cyclase activity.
    Golf S; Myhre E; Abdelnoor M; Andersen D; Hansson V
    Cardiovasc Res; 1985 Nov; 19(11):693-9. PubMed ID: 3000595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanism of beta-adrenergic receptor blockers with intrinsic sympathomimetic activity.
    Jasper JR; Michel MC; Insel PA
    FASEB J; 1988 Oct; 2(13):2891-4. PubMed ID: 2901994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the intrinsic activity (efficacy) of human adrenergic receptors. Co-expression of beta 1 and beta 2 reveals a lower efficacy for the beta 1 receptor.
    Birnbaumer L; Levy FO; Zhu X; Kaumann AJ
    Tex Heart Inst J; 1994; 21(1):16-21. PubMed ID: 8180506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.